Social participation and mental health of immunocompromised individuals before and after COVID-19 vaccination-Results of a longitudinal observational study over three time points.
COVID-19
SARS-CoV-2 vaccination
immunocompromised persons
longitudinal study
mental health status
observational study
quality of life
social participation
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
10
2022
accepted:
29
11
2022
entrez:
2
1
2023
pubmed:
3
1
2023
medline:
3
1
2023
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic impacted how people perform their daily lives in manifold and sometimes massive ways. Particularly, individuals who are at high risk for a severe disease progression, like immunocompromised people, may have experienced drastic changes in social participation during the pandemic. A COVID-19 basic vaccination may have changed the safety behavior of immunocompromised individuals in terms of infection risk and thereby influence social participation and mental wellbeing. This study aims to investigate self-perceived social participation at baseline before and at follow-up 1 and 6 months after basic vaccination. Beginning in March 2021, 274 immunocompromised persons 18 years or older were enrolled in the COVID-19 Contact Immune study (CoCo study) in Lower Saxony, Germany. Measurements were performed at three time points regarding social participation [Index for the Assessment of Health Impairments (IMET)], mental health [Patient Health Questionnaire-4 (PHQ-4)], subjective health status (five-point Likert-scale) and quality of life (five-point Likert-scale). In total, 126 participants were included in the final analysis. About 60% of the participants showed increasing social participation over time. The greatest increase in social participation was observed within the first month after basic vaccination ( It is unclear why social participation increased after basic vaccination. Perceived vaccine efficacy and a feeling of being protected by the vaccine may have caused relaxed social distancing behaviors. Reducing safety behaviors may, however, increase the risk of a COVID-19 infection for immunocompromised individuals. Further investigations are needed to explore the health-related consequences of more social participation among immunocompromised persons.
Identifiants
pubmed: 36590634
doi: 10.3389/fpsyt.2022.1080106
pmc: PMC9795223
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1080106Informations de copyright
Copyright © 2022 Heesen, Heinemann, Müller, Dopfer-Jablonka, Mikuteit, Niewolik, Klawonn, Vahldiek, Hummers and Schröder.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Nutr Health Aging. 2021;25(9):1070-1075
pubmed: 34725663
Acta Biomed. 2020 Jul 20;91(9-S):87-89
pubmed: 32701921
Rehabilitation (Stuttg). 2015 Dec;54(6):402-8
pubmed: 26676739
Health Place. 2022 Mar;74:102772
pubmed: 35228058
Crit Care. 2020 Apr 28;24(1):179
pubmed: 32345311
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Rehabilitation (Stuttg). 2016 Aug;55(4):248-55
pubmed: 27529302
PLoS One. 2022 Feb 28;17(2):e0264357
pubmed: 35226661
Rheumatol Int. 2022 Feb;42(2):241-250
pubmed: 34846554
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
Front Psychol. 2017 Apr 07;8:456
pubmed: 28439244
BMC Infect Dis. 2022 Apr 25;22(1):403
pubmed: 35468758
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Psychother Psychosom Med Psychol. 2015 Jun;65(6):203
pubmed: 26086851
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Medwave. 2021 May 24;21(4):e8186
pubmed: 34086666
BMJ Open Gastroenterol. 2021 Feb;8(1):
pubmed: 33579729
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):674-684
pubmed: 28466129
ACR Open Rheumatol. 2020 Jun;2(6):335-343
pubmed: 32311836
Lancet. 2020 May 30;395(10238):1676-1678
pubmed: 32380042
Psychol Med. 2022 Oct;52(13):2549-2558
pubmed: 33183370
Front Med (Lausanne). 2022 Mar 14;9:792881
pubmed: 35360744
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Int J Environ Res Public Health. 2021 Dec 27;19(1):
pubmed: 35010515
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Front Psychol. 2021 Oct 20;12:759987
pubmed: 34744938
Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI180-SI188
pubmed: 35143648
PLoS One. 2021 Sep 8;16(9):e0256406
pubmed: 34496006
Front Psychiatry. 2019 Jan 10;9:762
pubmed: 30687141
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1459-1468
pubmed: 33569650
Lancet. 2022 Jun 25;399(10344):2381-2397
pubmed: 35247311
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
JAMA. 2021 Jun 1;325(21):2204-2206
pubmed: 33950155
Psychiatr Prax. 2020 Sep;47(6):308-318
pubmed: 32688427